drugset / Trial / NCT00108251
Aldosterone Antagonism in Diastolic Heart Failure
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to determine whether eplerenone has a beneficial effect on improving exercise ability in patients with diastolic heart failure.
Timeline
- Start
- 2004-08
- Primary completion
- 2007-09
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eplerenone | Unknown | 50 mg | — |